SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER - ANVISA Registration 80117581192

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE MONITORING IN INTERSTITIAL FLUID (PERCUTANEOUS) - SENSOR/TRANSMITTER in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80117581192 and manufactured by manufacturer not specified. The registration is held by EMERGO BRAZIL IMPORT IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS HOSPITALARES LTDA with validity until Nov 25, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including ABBOTT DIABETES CARE LTD, MICROTECH MEDICAL (HANGZHOU) CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.